查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572981

生物医学测试和分析服务市场：按技术、最终用户、测试类型、样本类型 - 2025-2030 年全球预测

Biomedical Testing & Analysis Services Market by Technology, End Users, Test Type, Sample Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物医学测试和分析服务市值为31.7亿美元，预计2024年将达到33.8亿美元，复合年增长率为7.94%，到2030年将达到54.2亿美元，预计将达到1000万美元。

生物医学测试和分析服务市场涵盖广泛的诊断和分析服务，旨在分析生物样本以进行疾病诊断、治疗监测和高级研究。它透过提供重要资料来指导临床决策并确保治疗方法的安全性和有效性，在医疗保健中发挥关键作用。主要应用包括病理学、毒理学、基因检测和临床检测，最终用户包括医院、研究机构、製药公司和生物技术公司。市场成长主要受到慢性病盛行率上升、诊断中自动化和人工智慧等技术进步以及对个人化医疗日益重视的影响。此外，COVID-19 大流行加速了对快速、准确检测解决方案的需求，为市场扩张提供了利润丰厚的机会。值得注意的机会在于开拓可携式诊断解决方案、扩展到新兴市场以及与高科技公司合作创新人工智慧主导的分析工具。

主要市场统计
基准年[2023] 31.7亿美元
预测年份 [2024] 33.8亿美元
预测年份 [2030] 54.2亿美元
复合年增长率（%） 7.94%

然而，仍存在一些限制和挑战，包括严格的法律规范、与先进诊断技术相关的高成本以及资料隐私和安全问题。此外，缺乏熟练的专业人员以及将新技术融入现有医疗基础设施的复杂性也可能阻碍市场成长。非侵入性检测、即时资料分析和生物银行等领域的创新提供了巨大的业务成长潜力。在降低成本的同时提高测试速度和准确性的研究至关重要。适应不断变化的监管要求并专注于策略伙伴关係关係也可能支持市场成功。鑑于该市场的竞争性质，企业必须利用数位技术的进步来改善服务交付并最大限度地提高客户满意度。透过预测市场趋势并积极应对现有挑战，公司可以在这个充满活力且快速发展的细分市场中获得优势。

市场动态：揭示快速发展的生物医学测试和分析服务市场的关键市场洞察

供需的动态交互作用正在改变生物医学测试和分析服务市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对早期疾病检测和个人化医疗的需求不断增长推动生物医学检测市场
    • 技术和自动化的进步提高了生物医学测试服务的准确性和效率
    • 慢性病盛行率上升和人口老化促进生物医学检测服务的成长
    • 在药物开发和疾病治疗中越来越多地采用基因组学和蛋白​​质组学研究来推动市场
  • 市场限制因素
    • 难以确保生物医学测试和分析服务严格的监管要求和合规标准
    • 来自生物医学研究设施内部测试能力和先进自动化系统的激烈竞争
  • 市场机会
    • 透过生物技术公司和诊断实验室之间的合作促进创新
    • 对非侵入性检测方法的更多关注增加了医疗筛检的频率和可近性
    • 支持生物医学测试和分析进步的监管环境和资金筹措机会
  • 市场问题
    • 与生物医学测试和分析服务相关的资料隐私和安全问题
    • 缺乏熟练的专业人员，包括实验室技术人员、生物资讯学专家和临床研究人员

波特五力：驾驭生物医学测试与分析服务市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物医学测试和分析服务市场的外部影响

外部宏观环境因素在塑造生物医学测试和分析服务市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析了解生物医学测试和分析服务市场的竞争格局

对生物医学测试和分析服务市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物医学测试和分析服务市场供应商的绩效评估

FPNV 定位矩阵是评估生物医学测试和分析服务市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，规划生物医学测试和分析服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对生物医学测试和分析服务市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3. 塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对早期疾病检测和个人化治疗的需求不断增长推动生物医学检测市场
      • 技术和自动化的进步提高了生物医学测试服务的准确性和效率
      • 慢性病的增加和人口老化正在促进生物医学检测服务的成长
      • 在药物开发和疾病治疗中越来越多地采用基因组学和蛋白​​质组学研究推动了市场
    • 抑制因素
      • 难以确保生物医学测试和分析服务严格的监管要求和合规标准
      • 生物医学研究设施内部测试能力与先进自动化系统之间的激烈竞争
    • 机会
      • 生技公司和诊断实验室之间的合作加速创新
      • 促进更频繁、更方便的医疗诊断，并专注于非侵入性检测方法
      • 支持生物医学测试和分析进步的监管环境和资金筹措机会
    • 任务
      • 与生物医学测试和分析服务相关的资料隐私和安全问题
      • 实验室技术人员、生物资讯专家、临床研究人员等熟练专业人员短缺
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章生物医学测试与分析服务市场：依技术分类

  • 介绍
  • 基于细胞的测试
    • 细胞活力测定
    • 高内涵筛检
    • 活细胞成像
  • 临床化学
  • 血液学
  • 免疫检测
    • ELISA
    • 免疫检测
    • 西方墨点法
  • 质谱分析
    • 代谢体学
    • 蛋白质体学
  • 微生物检测
  • 分子诊断
    • DNA序列分析
    • 恒温核酸增幅
    • 微阵列
    • PCR

第七章生物医学测试和分析服务市场：按最终用户分类

  • 介绍
  • 生物技术和製药公司
  • 诊断实验室
  • 医院/诊所
  • 研究所和学术中心

第八章生物医学测试和分析服务市场：按测试类型

  • 介绍
  • 诊断
  • 初步检查
  • 预后
  • 筛检
  • 治疗监测

第九章生物医学测试和分析服务市场：按样本类型

  • 介绍
  • 血
  • 脑脊髓液
  • 唾液
  • 凳子
  • 组织切片检查
  • 尿

第十章美洲生物医学测试与分析服务市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太生物医学测试与分析服务市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲生物医学测试和分析服务市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-2B5802CFE404

The Biomedical Testing & Analysis Services Market was valued at USD 3.17 billion in 2023, expected to reach USD 3.38 billion in 2024, and is projected to grow at a CAGR of 7.94%, to USD 5.42 billion by 2030.

The Biomedical Testing & Analysis Services market encompasses a broad range of diagnostic and analytical services aimed at analyzing biological samples for disease diagnosis, therapeutic monitoring, and advanced research purposes. It plays a critical role in healthcare by providing essential data that guides clinical decision-making and ensures the safety and efficacy of treatment regimens. Key applications include pathology, toxicology, genetic testing, and clinical trials, with end-users ranging from hospitals, research institutes, and pharmaceutical companies to biotechnology firms. The market's growth is primarily influenced by the rising prevalence of chronic diseases, technological advancements such as automation and artificial intelligence in diagnostics, and the increasing emphasis on personalized medicine. Furthermore, the COVID-19 pandemic has accelerated the demand for rapid and accurate testing solutions, providing lucrative opportunities for market expansion. Noteworthy opportunities lie in the development of portable diagnostic solutions, expansion into emerging markets, and collaboration with tech companies to innovate AI-driven analytical tools.

KEY MARKET STATISTICS
Base Year [2023] USD 3.17 billion
Estimated Year [2024] USD 3.38 billion
Forecast Year [2030] USD 5.42 billion
CAGR (%) 7.94%

However, some limitations and challenges persist, such as stringent regulatory frameworks, high costs associated with advanced diagnostic technologies, and issues related to data privacy and security. Additionally, market growth could be hindered by a shortage of skilled professionals and the complexities of integrating new technologies within existing healthcare infrastructures. Innovating in areas like non-invasive testing methods, real-time data analytics, and biobanking could offer substantial business growth potential. Research into enhancing test speed and accuracy, while reducing costs, will be essential. Adapting to the evolving landscape of regulatory requirements and focusing on strategic partnerships can also drive market success. Considering the competitive nature of this market, companies should leverage advancements in digital technology to improve service delivery and maximize customer satisfaction. By anticipating market trends and addressing existing challenges proactively, businesses can stay ahead in this dynamic and rapidly evolving sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomedical Testing & Analysis Services Market

The Biomedical Testing & Analysis Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
    • Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
    • Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
    • Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
  • Market Restraints
    • Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
    • Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
  • Market Opportunities
    • Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
    • Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
    • Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
  • Market Challenges
    • Data privacy and security concerns associated with biomedical testing & analysis services
    • Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher

Porter's Five Forces: A Strategic Tool for Navigating the Biomedical Testing & Analysis Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomedical Testing & Analysis Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomedical Testing & Analysis Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomedical Testing & Analysis Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomedical Testing & Analysis Services Market

A detailed market share analysis in the Biomedical Testing & Analysis Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomedical Testing & Analysis Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomedical Testing & Analysis Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomedical Testing & Analysis Services Market

A strategic analysis of the Biomedical Testing & Analysis Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomedical Testing & Analysis Services Market, highlighting leading vendors and their innovative profiles. These include BioIVT, BioReliance Corporation, Charles River Laboratories International, Inc., Covance Inc., Envigo, Eurofins Scientific, Frontage Laboratories, Inc., ICON Central Laboratories, ICON plc, Inotiv, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Medpace Holdings, Inc., Parexel International Corporation, Pharmaceutical Product Development, LLC, PPD, Inc., PRA Health Sciences, Inc., SGS SA, Syneos Health, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Biomedical Testing & Analysis Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Cell-Based Tests, Clinical Chemistry, Hematology, Immunoassays, Mass Spectrometry, Microbiological Testing, and Molecular Diagnostics. The Cell-Based Tests is further studied across Cell Viability Assays, High Content Screening, and Live Cell Imaging. The Immunoassays is further studied across ELISA, Radioimmunoassay, and Western Blot. The Mass Spectrometry is further studied across Metabolomics and Proteomics. The Molecular Diagnostics is further studied across DNA Sequencing, Isothermal Nucleic Acid Amplification, Microarray, and PCR.
  • Based on End Users, market is studied across Biotechnology & Pharmaceutical Companies, Diagnostic Laboratories, Hospitals & Clinics, and Research Institutions & Academic Centers.
  • Based on Test Type, market is studied across Diagnostic, Preliminary Testing, Prognostic, Screening, and Therapeutic Monitoring.
  • Based on Sample Type, market is studied across Blood, Cerebrospinal Fluid, Saliva, Stool, Tissue Biopsy, and Urine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
      • 5.1.1.2. Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
      • 5.1.1.3. Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
      • 5.1.1.4. Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
    • 5.1.2. Restraints
      • 5.1.2.1. Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
      • 5.1.2.2. Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
      • 5.1.3.2. Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
      • 5.1.3.3. Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy and security concerns associated with biomedical testing & analysis services
      • 5.1.4.2. Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biomedical Testing & Analysis Services Market, by Technology

  • 6.1. Introduction
  • 6.2. Cell-Based Tests
    • 6.2.1. Cell Viability Assays
    • 6.2.2. High Content Screening
    • 6.2.3. Live Cell Imaging
  • 6.3. Clinical Chemistry
  • 6.4. Hematology
  • 6.5. Immunoassays
    • 6.5.1. ELISA
    • 6.5.2. Radioimmunoassay
    • 6.5.3. Western Blot
  • 6.6. Mass Spectrometry
    • 6.6.1. Metabolomics
    • 6.6.2. Proteomics
  • 6.7. Microbiological Testing
  • 6.8. Molecular Diagnostics
    • 6.8.1. DNA Sequencing
    • 6.8.2. Isothermal Nucleic Acid Amplification
    • 6.8.3. Microarray
    • 6.8.4. PCR

7. Biomedical Testing & Analysis Services Market, by End Users

  • 7.1. Introduction
  • 7.2. Biotechnology & Pharmaceutical Companies
  • 7.3. Diagnostic Laboratories
  • 7.4. Hospitals & Clinics
  • 7.5. Research Institutions & Academic Centers

8. Biomedical Testing & Analysis Services Market, by Test Type

  • 8.1. Introduction
  • 8.2. Diagnostic
  • 8.3. Preliminary Testing
  • 8.4. Prognostic
  • 8.5. Screening
  • 8.6. Therapeutic Monitoring

9. Biomedical Testing & Analysis Services Market, by Sample Type

  • 9.1. Introduction
  • 9.2. Blood
  • 9.3. Cerebrospinal Fluid
  • 9.4. Saliva
  • 9.5. Stool
  • 9.6. Tissue Biopsy
  • 9.7. Urine

10. Americas Biomedical Testing & Analysis Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biomedical Testing & Analysis Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biomedical Testing & Analysis Services Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BioIVT
  • 2. BioReliance Corporation
  • 3. Charles River Laboratories International, Inc.
  • 4. Covance Inc.
  • 5. Envigo
  • 6. Eurofins Scientific
  • 7. Frontage Laboratories, Inc.
  • 8. ICON Central Laboratories
  • 9. ICON plc
  • 10. Inotiv, Inc.
  • 11. IQVIA Holdings Inc.
  • 12. Laboratory Corporation of America Holdings
  • 13. Medpace Holdings, Inc.
  • 14. Parexel International Corporation
  • 15. Pharmaceutical Product Development, LLC
  • 16. PPD, Inc.
  • 17. PRA Health Sciences, Inc.
  • 18. SGS SA
  • 19. Syneos Health
  • 20. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL VIABILITY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY LIVE CELL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS & ACADEMIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PRELIMINARY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STOOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 217. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 225. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 226. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 233. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 234. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 235. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 241. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 242. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 243. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 249. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 250. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 251. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 257. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 258. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 259. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 265. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 266. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 267. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 274. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 281. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 282. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 283. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY BIOMEDICAL TESTING & ANALYSIS SERVICES MARK